- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03917810
Acute Responses to Manipulating Dietary Carbohydrate Content on Free-living Physical Activity Energy Expenditure
Dietary sugar and carbohydrate intakes will be manipulated for 3 days in a randomised crossover design. All food will be provided. Free-living physical activity energy expenditure will be measured using combined heart rate and accelerometry. Metabolic and appetite/mood responses to 3 days on each diet will be measured.
Each participant will undergo 3 days of each diet:
- Moderate sugar - reflecting the composition of a typical European diet
- Low sugar - similar macronutrient composition of a typical European diet but with <5% energy intake from free sugars (as per government guidelines)
- Low carbohydrate - low carbohydrate diet with <5% energy intake from sugar and <8% energy intake from carbohydrate, replacing carbohydrate energy with fat
Visão geral do estudo
Descrição detalhada
Guidelines calling for dietary free sugars to be reduced have been formulated from evidence that diets high in sugar are associated with high energy intake. In theory, by reducing the intake of sugars, calorie surplus will be reduced and energy balance will be maintained. However, when referring to interventions/behaviours that influence energy balance, both sides of the energy balance equation need to be considered. Alterations in nutrients may influence aspects of energy expenditure, not solely energy intake, and this may have implications for the efficacy of guidelines seeking to influence energy intake.
It is important to consider energy expenditure in the context of health. The most variable component of energy expenditure between individuals is physical activity energy expenditure (PAEE), which varies from ~600-2100 kcal per day in men of a similar demographic. Current guidelines do not regard the effect that changing dietary sugar might have on PAEE and therefore total energy expenditure.
Furthermore, there is increasing interest in restricting overall carbohydrate intake to treat metabolic disease or achieve ketogenesis. Very little is known about nutrition-physical activity interactions with this type of intervention.
This study will prescribe 3 diets to healthy males for 3 days in a randomised crossover design, where each participant will consume each of the diets. All food will be prepared and provided by the study team. The diets are as follows:
- Moderate sugar - reflecting the composition of a typical European diet
- Low sugar - similar macronutrient composition of a typical European diet but with <5% energy intake from free sugars (as per government guidelines)
- Low carbohydrate - low carbohydrate diet with <5% energy intake from sugar and <8% energy intake from carbohydrate, replacing carbohydrate energy with fat
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Somerset
-
Bath, Somerset, Reino Unido, BA2 7AY
- University of Bath
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Body mass index 18.5-29.9 kg∙m-2
- Age 18-65 years
- Male
- Able and willing to provide informed consent and safely comply with study procedures
- No anticipated changes in physical activity during the study (e.g. holidays)
Exclusion Criteria:
- Any reported condition or behaviour deemed either to pose undue personal risk to the participant or introduce bias
- Any diagnosed metabolic disease (e.g. type 1 or type 2 diabetes)•Any reported use of substances which may pose undue personal risk to the participants or introduce bias into the experiment
- Lifestyle not conforming to standard sleep-wake cycle (e.g. shift worker)
- Any reported recent (<6 months) change in body mass (±3%)
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Ciência básica
- Alocação: Randomizado
- Modelo Intervencional: Atribuição cruzada
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: MODSUG
Diet consisting of 50% carbohydrate (20% sugar), 15% protein, 35% fat
|
A composição de macronutrientes (especificamente tipo e/ou quantidade de carboidrato) é manipulada
|
|
Experimental: LOWSUG
Diet consisting of 50% carbohydrate (<5% sugar), 15% protein, 35% fat
|
A composição de macronutrientes (especificamente tipo e/ou quantidade de carboidrato) é manipulada
|
|
Experimental: LOWCHO
Diet consisting of <8% carbohydrate (<5% sugar), 15% protein, >77% fat
|
A composição de macronutrientes (especificamente tipo e/ou quantidade de carboidrato) é manipulada
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Physical activity energy expenditure (kj/day or kcal/day)
Prazo: 3 days
|
Physical activity energy expenditure measured using individually-calibrated combined heart rate and accelerometry (kj/day or kcal/day)
|
3 days
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Time spent in different physical activity intensities (MET categories) (minutes)
Prazo: 3 days
|
Time spent in different physical activity intensities (MET categories) (minutes) using individually-calibrated combined heart rate and accelerometry
|
3 days
|
|
Energy expended in different physical activity intensities (MET categories) (kJ/day or kcal/day)
Prazo: 3 days
|
Energy expended in different physical activity intensities (MET categories) (kJ/day or kcal/day) using individually-calibrated combined heart rate and accelerometry
|
3 days
|
|
Energy expended in the postprandial period (kJ or kcal)
Prazo: 3 days
|
Energy expended in the postprandial period (kJ or kcal) measured using individually-calibrated combined heart rate and accelerometry
|
3 days
|
|
Fasting blood glucose concentrations
Prazo: 3 days
|
Measures of blood glucose concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood insulin concentrations
Prazo: 3 days
|
Measures of blood insulin concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood triglyceride concentrations
Prazo: 3 days
|
Measures of blood triglyceride concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood non-esterified fatty acid concentrations
Prazo: 3 days
|
Measures of blood non-esterified fatty acid concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood lactate concentrations
Prazo: 3 days
|
Measures of blood lactate concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood beta-hydroxybutyrate concentrations
Prazo: 3 days
|
Measures of blood beta-hydroxybutyrate concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood leptin concentrations
Prazo: 3 days
|
Measures of blood leptin concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood fibroblast growth factor-21 concentrations
Prazo: 3 days
|
Measures of blood fibroblast growth factor-21 concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood total cholesterol concentrations
Prazo: 3 days
|
Measures of blood total cholesterol concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood high density lipoprotein concentrations
Prazo: 3 days
|
Measures of blood high density lipoprotein concentrations pre- and post-intervention.
|
3 days
|
|
Fasting blood low density lipoprotein concentrations
Prazo: 3 days
|
Measures of blood low density lipoprotein concentrations pre- and post-intervention.
|
3 days
|
|
Food preference ratings
Prazo: 3 days
|
Food preference ratings determined by computer task measured pre- and post-intervention
|
3 days
|
|
Subjective appetite and mood ratings
Prazo: 3 days
|
Measured by 0-100 mm visual analogue scales measured pre- and post-intervention
|
3 days
|
|
Blood pressure
Prazo: 3 days
|
Blood pressure using an automated sphygmomanometer pre- and post-intervention
|
3 days
|
Colaboradores e Investigadores
Patrocinador
Publicações e links úteis
Publicações Gerais
- Betts JA, Richardson JD, Chowdhury EA, Holman GD, Tsintzas K, Thompson D. The causal role of breakfast in energy balance and health: a randomized controlled trial in lean adults. Am J Clin Nutr. 2014 Aug;100(2):539-47. doi: 10.3945/ajcn.114.083402. Epub 2014 Jun 4.
- Smith HA, Gonzalez JT, Thompson D, Betts JA. Dietary carbohydrates, components of energy balance, and associated health outcomes. Nutr Rev. 2017 Oct 1;75(10):783-797. doi: 10.1093/nutrit/nux045.
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- EP 17/18 219
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .